Clinical Trial Results

Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

PHASE2, PHASE3INTERVENTIONAL Murrieta, California +4 more

RECRUITING

Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease

NAINTERVENTIONAL Tucson, Arizona +3 more

RECRUITING

A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

PHASE3INTERVENTIONAL Long Beach, California +4 more

RECRUITING

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

NAINTERVENTIONAL Delray Beach, Florida +4 more

RECRUITING

Dominantly Inherited Alzheimer Network (DIAN)

N/AOBSERVATIONAL Jacksonville, Florida +4 more

RECRUITING

Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients

NAINTERVENTIONAL Menands, New York +1 more

RECRUITING

A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

PHASE2INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

PHASE2INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's Disease

PHASE2INTERVENTIONAL New York, New York

RECRUITING

Clinical Trial on Agitation in Alzheimer's Dementia

PHASE2INTERVENTIONAL Maitland, Florida +4 more

RECRUITING

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Aβ Dynamics in LLMD

PHASE4INTERVENTIONAL New York, New York +1 more

RECRUITING

Innate Immunity Stimulation Via TLR9 in Early AD

PHASE1INTERVENTIONAL New York, New York

RECRUITING

Late Onset Alzheimer's Disease

N/AOBSERVATIONAL Washington D.C., District of Columbia +4 more

RECRUITING

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

PHASE3INTERVENTIONAL Homewood, Alabama +4 more

RECRUITING

Triage Survey for Neurology Research Eligibility

N/AOBSERVATIONAL Boston, Massachusetts +2 more

RECRUITING

Autoimmune Features of Neurodegenerative Disorders

N/AOBSERVATIONAL New York, New York

RECRUITING

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Evaluating the Efficacy of the Pain Identification and Communication Toolkit

NAINTERVENTIONAL New York, New York

RECRUITING

Early Age-Related Hearing Loss Investigation (EARHLI)

NAINTERVENTIONAL New York, New York

RECRUITING

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

PHASE3INTERVENTIONAL Homewood, Alabama +4 more

RECRUITING

NYSCF Scientific Discovery Biobank

N/AOBSERVATIONAL New York, New York

RECRUITING

Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease

PHASE2INTERVENTIONAL New York, New York

RECRUITING